FDA has opened a public docket and is requesting comments on proposed criteria for “first generic” abbreviated new drug application submissions.
Connie Curran, 67, the first executive director of C-Change, died Nov. 10.
The American Society of Clinical Oncology has proposed a set of principles for shaping future debate of the role of Medicaid.
Projects support product development, prevention and research advancements across Texas
As an oncologist who treats sarcoma, George Demetri has seen the adverse consequences of power morcellation, the surgical technique widely used to perform laparoscopic hysterectomies and remove putative fibroids.
An interview with Amy Reed, formerly an anesthesiologist at Beth Israel Deaconess Medical Center, and Hooman Noorchashm, formerly a cardiothoracic surgeon at Brigham & Women's Hospital.Debate Over Brigham's Containment Bag StudyFDA's other option is to mandate creation of a post-market surveillance study combining power morcellators with a containment system or bag, which would be used to prevent the dissemination of any tissue, benign or malignant.
Here is what we know: A surgical device used to perform about 100,000 hysterectomies and myomectomies every year in the U.S. has been shown to spread cells from undetected or missed uterine cancers—rapidly upstaging the disease.
The Breakthrough Prize Foundation announced the recipients of its prizes in life sciences and fundamental physics, who will receive awards of $3 million.The recipients of the 2015 Breakthrough Prizes in Life Sciences are:
About eight million women ages 21 to 65 years have not been screened for cervical cancer in the past five years, according to the Centers for Disease Control and Prevention. More than half of new cervical cancer cases occur among women who have never or rarely been screened.
The Cancer Prevention & Research Institute of Texas is adding rare cancers and childhood cancers to its list of funding priorities, according to a draft program report.
